Fig. 2From: SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional studyProportion of participants with SARS-CoV-2 infection in MATAEA and two other serosurveys. LIs: Leeward Islands; WIs: Windward Islands. (1) Seroprevalence survey conducted in Tahiti and Moorea in February 20218. (2) Seroprevalence survey conducted in Tahiti during November–December 202111. *Confidence intervals were calculated based on the hypothesis of binomial distributionBack to article page